Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 3/20 | 0.52 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.52 |
| ▸ | LGALS4 | P56470 | 3/20 | 0.52 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | AMY2A | P04746 | 2/20 | 0.47 |
| ▸ | GJA1 | P17302 | 1/20 | 0.45 |
| ▸ | GJB2 | P29033 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | TYR | P14679 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12787242 | 1.00 | LGALS8 (0.52) | LGALS8LGALS3LGALS4AMY1AMEN1 | |
| SCHEMBL12787180 | 1.00 | LGALS8 (0.52) | LGALS8LGALS3LGALS4AMY1AMEN1 | |
| SCHEMBL10136109 | 1.00 | LGALS8 (0.52) | LGALS8LGALS3LGALS4AMY1AMEN1 | |
| SCHEMBL12787189 | 1.00 | LGALS8 (0.52) | LGALS8LGALS3LGALS4AMY1AMEN1 | |
| SCHEMBL12787186 | 1.00 | LGALS8 (0.52) | LGALS8LGALS3LGALS4AMY1AMEN1 | |
| SCHEMBL18934157 | 0.93 | AMY1A (0.47) | LGALS8LGALS3LGALS4AMY1AMEN1 | |
| SCHEMBL16190428 | 0.93 | AMY1A (0.47) | LGALS8LGALS3LGALS4AMY1AMEN1 | |
| SCHEMBL24030696 | 0.91 | LGALS8 (0.51) | LGALS8LGALS3LGALS4AMY1AMEN1 | |
| SCHEMBL17948323 | 0.91 | AMY1A (0.43) | LGALS8LGALS3LGALS4AMY1AMEN1 | |
| SCHEMBL17948322 | 0.91 | AMY1A (0.43) | LGALS8LGALS3LGALS4AMY1AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9402925-B2 | Probes and methods of imaging a bacterial infection | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIO (US) | 2016-08-02 | — | — | US | disclosed |
| US-8802841-B2 | 1,2-dideoxy-1,2-diamino oligosaccharides and polysaccharides and derivatives thereof | GLYCOM A/S (DK) | 2014-08-12 | — | — | US | disclosed |
| US-8802841-B2 | 1,2-dideoxy-1,2-diamino oligosaccharides and polysaccharides and derivatives thereof | GLYCOM A/S (DK) | 2014-08-12 | — | — | US | disclosed |
| US-20120070382-A1 | FLUORESCENT CONJUGATED POLYMERS WITH A BODIPY-BASED BACKBONE AND USES THEREOF | MICHIGAN TECHNOLOGICAL UNIVERSITY (US) | 2012-03-22 | — | — | US | disclosed |
| US-20110060139-A1 | CARBOHYDRATE DERIVATIVES | GLYCOM A/S (DK) | 2011-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110060139-A1 | CARBOHYDRATE DERIVATIVES | ALG1, MAN2A1, MAN1B1 | LGALS8 309/4885LGALS3 245/4885LGALS4 291/4885 |
| US-20120070382-A1 | FLUORESCENT CONJUGATED POLYMERS WITH A BODIPY-BASED BACKBONE AND USES THEREOF | TLR3, TLR5, PARP15 | LGALS8 1606/4885LGALS3 399/4885LGALS4 524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.